CPT code 64418 represents a suprascapular nerve injection in which a provider administers an anesthetic agent and/or steroid near the suprascapular nerve above the scapula. This targeted nerve injection is used in the management of shoulder pain and can be performed as a diagnostic or therapeutic intervention. Nationally, it matters because suprascapular nerve injections are commonly used across outpatient and ambulatory settings to reduce pain, guide further management, and potentially avoid surgery.

Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find benchmarks for utilization and reimbursement practices across major payers, clinical context on indications and typical sites of service, and summaries of relevant policy elements affecting coverage and prior authorization. The publication also outlines billing considerations specific to 64418, payer variability, and common documentation expectations. Data not available in the input is noted where applicable.